| 000 | 01505 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513154248.0 | ||
| 264 | 0 | _c19990208 | |
| 008 | 199902s 0 0 eng d | ||
| 022 | _a0022-510X | ||
| 024 | 7 |
_a10.1016/s0022-510x(98)00116-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndersson, P B | |
| 245 | 0 | 0 |
_aGlucocorticosteroid therapy for multiple sclerosis: a critical review. _h[electronic resource] |
| 260 |
_bJournal of the neurological sciences _cSep 1998 |
||
| 300 |
_a16-25 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAutoantigens _ximmunology |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aModels, Immunological |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aOptic Neuritis _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSteroids |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aGoodkin, D E | |
| 773 | 0 |
_tJournal of the neurological sciences _gvol. 160 _gno. 1 _gp. 16-25 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-510x(98)00116-6 _zAvailable from publisher's website |
| 999 |
_c9768474 _d9768474 |
||